| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US8829186 | MEDICURE | Method for preparation of pitavastatin and pharmaceutical acceptable salts thereof |
Jan, 2031
(7 years from now) | |
Zypitamag is owned by Medicure.
Zypitamag contains Pitavastatin Magnesium.
Zypitamag has a total of 1 drug patent out of which 0 drug patents have expired.
Zypitamag was authorised for market use on 14 July, 2017.
Zypitamag is available in tablet;oral dosage forms.
The generics of Zypitamag are possible to be released after 19 January, 2031.
Drugs and Companies using PITAVASTATIN MAGNESIUM ingredient
Market Authorisation Date: 14 July, 2017
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
ZYPITAMAG family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic